Jingjiu Health (00648) issued an announcement. On April 21, 2024, the Stock Exchange informed that it will not exercise its right to delist the company in accordance with section 6.01A (2) (b) (i) of the listing rules, subject to further developments in the company's petition to the Securities Regulatory Commission, and may exercise its rights in accordance with section 6.01A of the Listing Rules at a later stage if it deems appropriate. The company will continue to gradually address the concerns of the Securities Regulatory Commission and the Stock Exchange.
The company is mainly engaged in the distribution of medical equipment and products in Hong Kong, which involves the medical business of dental equipment and products. The Group's business operations are carried out as usual in all major aspects. The Board will continue to evaluate and monitor the impact of the suspension of trading on the Group's operating and financial performance, and take appropriate measures (including issuing announcements relating to its business operations) where appropriate.